Log in

Enanta Pharmaceuticals SEC Filings & 10K Form (NASDAQ:ENTA)

$50.88
+1.06 (+2.13 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
$48.10
Now: $50.88
$51.29
50-Day Range
$49.82
MA: $54.53
$58.93
52-Week Range
$48.10
Now: $50.88
$106.80
Volume308,994 shs
Average Volume205,228 shs
Market Capitalization$1.01 billion
P/E Ratio31.41
Dividend YieldN/A
Beta0.85

SEC Filings

Enanta Pharmaceuticals (NASDAQ:ENTA) SEC Filings

DateFilerForm TypeView
02/28/2020
4:24 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:18 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:07 AM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:06 AM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:05 AM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:04 AM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:03 AM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:19 AM
Enanta Pharmaceuticals (Subject)
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/13/2020
9:33 AM
Enanta Pharmaceuticals (Subject)
SHIONOGI & CO LTD (Filed by)
Form SC 13G/A
02/04/2020
10:53 AM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2020
11:35 AM
Dworsky Alan J (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/06/2020
5:21 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:20 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:19 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:18 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:17 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/21/2019
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
5:48 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:47 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:45 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:44 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:44 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
4:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:45 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:25 PM
Enanta Pharmaceuticals (Subject)
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
08/09/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
5:33 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:32 PM
Enanta Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
3:13 PM
Enanta Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
3:01 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:04 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:51 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:20 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:15 PM
Enanta Pharmaceuticals (Filer)
Form 8-K/A
03/06/2019
4:00 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
3:51 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:14 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:06 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:05 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:04 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:03 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:03 PM
Buckley Stephen Jr. (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:50 PM
Enanta Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/13/2019
8:40 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:33 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:28 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:21 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:16 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
7:57 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
7:50 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
1:11 PM
Enanta Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/11/2019
9:31 AM
Enanta Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
Form SC 13G/A
02/08/2019
8:40 AM
Dworsky Alan J (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/24/2019
4:21 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:13 PM
Enanta Pharmaceuticals (Filer)
Form DEFA14A
01/18/2019
3:07 PM
Enanta Pharmaceuticals (Subject)
Luly Jay R. (Filed by)
Form SC 13D
01/18/2019
3:05 PM
Enanta Pharmaceuticals (Filer)
Form DEF 14A
12/06/2018
7:35 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
4:42 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/26/2018
3:07 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2018
7:35 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
7:22 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
7:13 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
7:04 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
6:57 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
6:45 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:22 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:21 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4/A
10/02/2018
3:20 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
3:18 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2018
3:15 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4/A
08/21/2018
5:02 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2018
3:57 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2018
3:35 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2018
3:56 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:22 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
4:13 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
4:32 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
5:02 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
4:53 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
4:23 PM
Enanta Pharmaceuticals (Subject)
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
05/08/2018
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2018
4:34 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
5:39 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:36 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:31 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:27 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:23 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:19 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
6:14 PM
Buckley Stephen Jr. (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
5:28 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
5:28 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
5:27 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
5:27 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel